Givaudan, Symrise, DSM shares drop on global fragrance cartel probe
Givaudan, Symrise, IFF, Firmenich named in Swiss cartel probe
Shares in companies drop by more than 2%, underperforming market
Switzerland joins EU, UK, U.S. investigations
Adds analyst, Firmenich comments
By Ludwig Burger and John Stonestreet
March 8 (Reuters) -Shares in Givaudan GIVN.S and Symrise SY1G.DE took a beating on Wednesday after the Swiss antitrust agency named them as part of a quartet of companies in the crosshairs of international competition watchdogs.
Swiss competition commission COMCO said its probe was targeting market leaders Givaudan, domestic rival Firmenich, which is merging with Dutch chemicals group DSM DSMN.AS, U.S.-based International Flavors & Fragrances IFF.N and Germany's Symrise SY1G.DE.
The more than $5 billion scents industry creates and makes fine fragrances for brands including Calvin Klein, Hugo Boss BOSSn.DE and Gucci, while also designing the smell of household products of global companies such as Procter & Gamble PG.N and Colgate-Palmolive CL.N.
News of the probe into the supply of fragrances and fragrance ingredients broke late on Tuesday, when Givaudan confirmed it was being investigated. The Swiss authorities were the first to name all companies involved.
Shares of Symrise, which on Wednesday forecast a 2023 core profit margin slightly below market expectations, dropped 2.6% at 1158 GMT, though the company's chief executive said he did not expect the firm to be affected and its role was primarily that of a witness.
Givaudan dropped 2.8% and DSM lost 3.1%, underperforming a 1% decline in the STOXX Europe 600 Chemicals index .SX4P, while U.S.-listed International Flavors & Fragrances (IFF) was down 2.9% at Tuesday's close.
COMCO said several raids were carried out in conjunction with the European Commission, the U.S. Department of Justice Antitrust Division and the UK Competition and Markets Authority.
The Swiss agency added it acted on suspicion the companies "coordinated their pricing policy, prohibited their competitors from supplying certain customers and limited the production of certain fragrances".
It said that the ingredients in question are used in cosmetics, personal care products, detergents and cleaning products.
"If these concerns prove true it would mean a substantial reputational damage for the fragrance sector and also Givaudan, next to potential fines and future weaker negotiating power," analysts at Swiss brokerage Vontobel said.
The British watchdog on Tuesday set a deadline of early 2024 for analysing and reviewing information gathered from the companies.
Firmenich confirmed that antitrust authorities carried out unannounced inspections at its offices in France, Switzerland and Britain.
The company said it was closely monitoring the situation and fully cooperating with the investigators.
Spokespeople at Symrise and IFF also said the firms were cooperating with authorities.
Symrise said on Wednesday it had a 12% share of the combined market for fragrances, flavours, aroma chemicals and cosmetic ingredients last year, with Givaudan, IFF and Firmenich accounting for 18%, 22% and 11%, respectively.
The German company added that fragrances accounted for 13.2% of the 39 billion-euro overall market, working out to 5.1 billion euros ($5.37 billion) in industry fragrance revenue in 2022.
The upper limit of fines imposed for breaking EU competition law is 10% of a company's global revenue.
($1 = 0.9492 euros)
Reporting by Ludwig Burger in Frankfurt, John Stonestreet in London, Patricia Weiss in Frankfurt and Paul Arnold in Zurich; Editing by Jason Neely and Shounak Dasgupta
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
